BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8605591)

  • 1. Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival.
    Shepp DH; Moses JE; Kaplan MH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):460-8. PubMed ID: 8605591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Saillour F; Bernard N; Dequae-Merchadou L; Marimoutou C; Journot V; Dabis F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):171-8. PubMed ID: 9473020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus IgG and IgA serum antibodies in a study of HIV infection and HIV related diseases in homosexual men.
    Levy E; Margalith M; Sarov B; Sarov I; Rinaldo CR; Detels R; Phair J; Kaslow R; Ginzburg H; Saah AJ
    J Med Virol; 1991 Nov; 35(3):174-9. PubMed ID: 1666647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence and incidence of cytomegalovirus infection in patients infected with HIV-1. SEROCO group].
    Robain M; Carré N; Salmon-Ceron D; Dussaix E; Meyer L
    Presse Med; 1998 Jun; 27(20):949-53. PubMed ID: 9767834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Binquet C; Saillour F; Bernard N; Rougier MB; Leger F; Bonnal F; Dabis F
    Eur J Epidemiol; 2000 May; 16(5):425-32. PubMed ID: 10997829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
    J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group.
    Rabkin CS; Hatzakis A; Griffiths PD; Pillay D; Ragni MV; Hilgartner MW; Goedert JJ
    J Infect Dis; 1993 Nov; 168(5):1260-3. PubMed ID: 7710460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus disease in AIDS: the Edinburgh experience.
    Cheong I; Flegg PJ; Brettle RP; Welsby PD; Burns SM; Dhillon B; Leen CL; Gray JA
    Int J STD AIDS; 1992; 3(5):324-8. PubMed ID: 1327173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.
    Sabin CA; Phillips AN; Lee CA; Janossy G; Emery V; Griffiths PD
    Epidemiol Infect; 1995 Apr; 114(2):361-72. PubMed ID: 7705496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cytomegalovirus infection a co-factor in HIV-1 disease progression?
    Robain M; Boufassa F; Hubert JB; Dussaix E; Sadeg K; Meyer L
    Epidemiol Infect; 2000 Oct; 125(2):415-20. PubMed ID: 11117966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of cytomegalovirus infection among children between the ages of 4 and 12 years in Taiwan.
    Shen CY; Chang WW; Chang SF; Chao MF; Huang ES; Wu CW
    J Med Virol; 1992 May; 37(1):72-5. PubMed ID: 1320100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with cytomegalovirus in homosexual men.
    Coutinho RA; Wertheim-van Dillen P; Albrecht-van Lent P; Nagelkerke N; Kuipers H; van Bentum-van Haagen A; Rijsdijk T; van der Noordaa J
    Br J Vener Dis; 1984 Aug; 60(4):249-52. PubMed ID: 6331568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions.
    Lamster IB; Begg MD; Mitchell-Lewis D; Fine JB; Grbic JT; Todak GG; el-Sadr W; Gorman JM; Zambon JJ; Phelan JA
    Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):163-74. PubMed ID: 7936584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
    Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
    East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania.
    Brantsæter AB; Johannessen A; Holberg-Petersen M; Sandvik L; Naman E; Kivuyo SL; Rollag H; Bruun JN; Kvale D
    Int J Infect Dis; 2012 Dec; 16(12):e879-85. PubMed ID: 23031419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo.
    Brantsaeter AB; Liestøl K; Goplen AK; Dunlop O; Bruun JN
    Scand J Infect Dis; 2002; 34(1):50-5. PubMed ID: 11874165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
    Sabin CA; Devereux HL; Clewley G; Emery VC; Phillips AN; Loveday C; Lee CA; Griffiths PD
    J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
    Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.